Although AFP and CA19.9 are currently recommended as reference biomarkers for HCC and PDAC, respectively, several studies have highlighted significant limitations in their specificity, restricting their utility in early diagnosis and accurate disease stratification [12,13]. The gene discussed is AFP; the disease is hepatocellular carcinoma.